Abiopharma

Clinical trial NCT04322955 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 48 → 38 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04722146 updates: 1. completion date: 2027-10-05 → 2027-10-13 2. primary completion date: 2027-04-07 → 2025-10-13

Clinical trial NCT06662786: completion date: 2032-01-30 → 2032-01-20.

Clinical trial NCT02808780: enrollment: 537 → 535 participants.

Clinical trial NCT07485452 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-06-01 3. collaborators removed: Erasmus Medical Center

Clinical trial NCT06470048 updates: 1. completion date: 2030-07-15 → 2034-07-31 2. primary completion date: 2027-07-06 → 2027-07-30

Clinical trial NCT06499714 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2025-08-31 3. primary completion date: 2025-12-31 → 2025-08-31 4. enrollment: 90 → 91 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06331312 updates: 1. completion date: 2028-08-22 → 2028-05-08 2. primary completion date: 2028-08-22 → 2028-05-08

Clinical trial NCT06052631: start date: 2026-06-09 → 2026-06-10.

Clinical trial NCT06545929 updates: 1. collaborators added: Imbrium Therapeutics 2. collaborators removed: Purdue Pharma LP